From a clinical to commercial level, nm|OK is used for such tasks as:
Rapid assessment of the development status of thousands of products
By using nm|OK, executives can obtain an immediate assessment of the development status of:
Market research, due diligence and competitive assessment
By using nm|OK, executives can assess product/company acquisition options and licensing opportunities, allowing them to design competitive strategies. nm|OK is unique as it links products/technologies developed in-house with those being developed by others under various types of strategic alliances, to allow users to view comprehensive company pipelines. Also, global revenues are presented for major marketed oncology products to establish worldwide market opportunities.
Evaluation of proposals/reports submitted by third parties
By using nm|OK executives would speed up the preparation/review of proposals to perform custom projects and also ensure that the results of such assignments are representative of the status of the oncology sector in evaluation.
Evaluation of R&D investments
By accessing nm|OK, R&D executives are able to tap into a vast body of clinical and technological advances in this field and make informed decisions as to in-house research and collaborations with others.
Companies with expanding product lines in oncology can use nm|OK as an educational tool for executives during reassignment or upon the introduction of new products.
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887